Compare · head to head
Ascentage Pharma Group vs Astellas Pharma
Astellas Pharma ranks higher overall — 360 rank 100 vs 26.
Astellas Pharma leads on Value (85 vs 38), Quality (75 vs 29), Growth (62 vs 50) and Safety (66 vs 50). Ascentage Pharma Group leads on Sentiment (57 vs 50).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | China | Japan |
| Sector | Health Care | Health Care |
| Industry | Biotechnology | Pharmaceuticals |
| Size | Medium | X-Large |
| ISIN | KYG0519B1023 | JP3942400007 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 26 | 100 |
| Value | 38 | 85 |
| Quality | 29 | 75 |
| Growth | 50 | 62 |
| Safety | 50 | 66 |
| Sentiment | 57 | 50 |
| Quality details | ||
| Profitability | 24 | 69 |
| Cash Truth | 34 | 81 |
Ascentage Pharma Group vs Kyowa Hakko KirinAscentage Pharma Group vs Medical Developments InternationalAscentage Pharma Group vs MesoblastAscentage Pharma Group vs Telix PharmaceuticalsAdd a third stock →
Full analyses: Ascentage Pharma Group · Astellas Pharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100